Multiple Sclerosis (MS) is a potentially disabling autoimmune disease whereby autoactivated T and B cells attack and destroy protective myelin sheaths of the central nervous system(CNS).
Collagen-based hydrogels behave similarly to the native tissue microenvironment, thus are widely used as scaffolds for encapsulating cells or molecules like growth factors. Collagen solution is an injectable liquid until it crosslinks at 37 C and physiological pH.
Activation of hedgehog signaling pathway can facilitate stem cell proliferation and holds great promise in regenerative medicine for a variety of indications.
Tracking in vivo cell distribution, migration, and engraftment using conventional techniques including MRI, PET/CT and conventional optical imaging is often hindered by low resolution, radioactive risks, and limited tissue penetration depth.
Researchers at Stanford and the Chan Zuckerberg Biohub have developed a platform for characterizing a population of microbes using spectrally encoded beads.
Researchers at Stanford have developed a microparticle-based vaccine that in a single shot enables enhanced activation of CD8+ and/or CD4+ T cells to fight against infectious diseases and cancer.
Researchers at Stanford have developed a technique that leverages multifocal widefield optics to enable high-speed, synchronous, genetically-specified recording of neural activity across the entirety of mouse dorsal cortex at near-cellular resolution.
Stanford researchers at the Camarillo Lab have developed a neural-network based model that can provide real-time calculation of brain strain based on instrumented mouthguard kinematics signals.
The Heilshorn group has developed a platform for 3D bioprinting which stiffens the structure post-printing using chemistry that is completely bioorthogonal.
Researchers at Stanford and the Chan Zuckerberg Biohub have discovered cross reactive, broadly neutralizing human antibodies against all serotypes of dengue virus.
Engineered cytotoxic T cells are a promising class of cell therapies. These living drugs are capable of selectively killing blood cancers, such as acute myeloid leukemia (AML), and delaying its progression.